Patent details
EP1575966 Title: THERAPEUTIC QUINAZOLINE DERIVATIVES
Basic Information
- Publication number:
- EP1575966
- PCT Application Number:
- PCT/GB/2003/005640
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP037895620
- PCT Publication Number:
- WO/2004/058782
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- THERAPEUTIC QUINAZOLINE DERIVATIVES
- French Title of Invention:
- DERIVES THERAPEUTIQUES DE QUINAZOLINE
- German Title of Invention:
- THERAPEUTISCHE QUINAZOLIN-DERIVATE
- SPC Number:
Dates
- Filing date:
- 22/12/2003
- Grant date:
- 29/10/2008
- EP Publication Date:
- 29/10/2008
- PCT Publication Date:
- 15/07/2004
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 21/09/2005
- EP B1 Publication Date:
- 29/10/2008
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 22/12/2008
- Expiration date:
- 22/12/2023
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 22/12/2003
- Name:
- AstraZeneca AB
- Address:
- -, 151 85 Södertälje, Sweden (SE)
Inventor
- Name:
- MORTLOCK Andrew, Austen, AstraZeneca R & D
- Address:
- United Kingdom (GB)
Priority
- Priority Number:
- 02293240
- Priority Date:
- 24/12/2002
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- Main IPC Class:
- C07F 9/6558;
| Filing date | Document type | Number of pages |
|---|